 
                    
                KANGSTEM BIOTECH CO., LTD.
Develops stem cell therapies for rare diseases; offers culture media, cell platforms, and CDMO services.
217730 | KO
Overview
Corporate Details
- ISIN(s):
- KR7217730001
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 테헤란로 522 홍우빌딩 9층, 강남구
- Website:
- https://kangstem.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Kangstem Biotech Co., Ltd. is a biopharmaceutical company dedicated to the research and development of stem cell therapeutics for rare and incurable diseases. The company's core mission is to address unmet medical needs through innovative, next-generation biopharmaceuticals. In addition to its therapeutic pipeline, Kangstem Biotech operates several key business segments. These include the production and commercialization of specialized stem cell culture media and mediums, noted for their efficacy in mesenchymal stem cell proliferation. The company also provides a proprietary cell freezing and thawing platform and offers Contract Development and Manufacturing Organization (CDMO) services, leveraging its expertise in cell-based technologies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-01 00:00 | Major Shareholding Notification 주식등의대량보유상황보고서(일반) | Korean | 159.6 KB | ||
| 2025-08-28 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 25.1 KB | ||
| 2025-08-28 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 25.1 KB | ||
| 2025-08-28 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 25.1 KB | ||
| 2025-08-28 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 25.9 KB | ||
| 2025-08-28 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 25.1 KB | ||
| 2025-08-28 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 25.1 KB | ||
| 2025-08-28 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 25.1 KB | ||
| 2025-08-28 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 25.1 KB | ||
| 2025-08-28 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 25.9 KB | ||
| 2025-08-28 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 25.1 KB | ||
| 2025-08-26 00:00 | Major Shareholding Notification 주식등의대량보유상황보고서(일반) | Korean | 85.3 KB | ||
| 2025-08-26 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 25.2 KB | ||
| 2025-08-25 00:00 | Share Issue/Capital Change 증권발행결과(자율공시)               | Korean | 7.8 KB | ||
| 2025-08-25 00:00 | Share Issue/Capital Change 증권발행실적보고서 | Korean | 158.0 KB | 
Automate Your Workflow. Get a real-time feed of all KANGSTEM BIOTECH CO., LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for KANGSTEM BIOTECH CO., LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for KANGSTEM BIOTECH CO., LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value | 
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
 
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                    